Nanomedicines for Endometriosis: Lessons Learned from Cancer Research

被引:46
|
作者
Moses, Abraham S. [1 ]
Demessie, Ananiya A. [1 ]
Taratula, Olena [1 ]
Korzun, Tetiana [1 ]
Slayden, Ov D. [2 ]
Taratula, Oleh [1 ]
机构
[1] Oregon State Univ, Coll Pharm, 2730 S Moody Ave, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA
基金
美国国家卫生研究院;
关键词
endometriosis; imaging; nanomedicines; nanoparticles; therapies;
D O I
10.1002/smll.202004975
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Endometriosis is an incurable gynecological disease characterized by the abnormal growth of endometrium-like tissue, characteristic of the uterine lining, outside of the uterine cavity. Millions of people with endometriosis suffer from pelvic pain and infertility. This review aims to discuss whether nanomedicines that are promising therapeutic approaches for various diseases have the potential to create a paradigm shift in endometriosis management. For the first time, the available reports and achievements in the field of endometriosis nanomedicine are critically evaluated, and a summary of how nanoparticle-based systems can improve endometriosis treatment and diagnosis is provided. Parallels between cancer and endometriosis are also drawn to understand whether some fundamental principles of the well-established cancer nanomedicine field can be adopted for the development of novel nanoparticle-based strategies for endometriosis. This review provides the state of the art of endometriosis nanomedicine and perspective for researchers aiming to realize and exploit the full potential of nanoparticles for treatment and imaging of the disorder.
引用
收藏
页数:27
相关论文
共 50 条
  • [1] (Poly-cyanoacrylate) nanomedicines for cancer and beyond: Lessons learned
    Couvreur, P.
    JOURNAL OF CONTROLLED RELEASE, 2021, 334 : 318 - 326
  • [2] Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures
    He, Hongliang
    Liu, Lisha
    Morin, Emily E.
    Liu, Min
    Schwendeman, Anna
    ACCOUNTS OF CHEMICAL RESEARCH, 2019, 52 (09) : 2445 - 2461
  • [3] Intelligent designs for promising cancer cures: Lessons learned from preclinical assessment of nanomedicines
    Patri, Anil K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [4] Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona
    Caracciolo, Giulio
    NANOSCALE, 2018, 10 (09) : 4167 - 4172
  • [5] Surgical Antifragility Lessons Learned from Endometriosis Surgery
    Mikhail, Emad
    Roman, Horace
    JOURNAL OF GYNECOLOGIC SURGERY, 2024, 40 (05) : 316 - 318
  • [6] Opportunities and lessons learned from the Cancer Research Network.
    Kushi, Lawrence H.
    Brown, Jeffrey S.
    Buist, Diana S. M.
    Chubak, Jessica
    Doria-Rose, V. Paul
    Mazor, Kathleen M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (09) : 23 - 24
  • [7] Some methodologic lessons learned from cancer screening research
    Vernon, SW
    Briss, PA
    Tiro, JA
    Warnecke, RB
    CANCER, 2004, 101 (05) : 1131 - 1145
  • [8] Nanomedicines for cardiovascular diseases: Lessons learned and pathways forward
    Mao, Yi-an
    Shi, Xiaozhou
    Sun, Pingyuan
    Spanos, Michail
    Zhu, Liyun
    Chen, Hang
    Wang, Xiya
    Su, Chanyuan
    Jin, Yanjia
    Wang, Xu
    Chen, Xuerui
    Xiao, Junjie
    BIOMATERIALS, 2025, 320
  • [9] Lessons learned from psychotherapy research
    Mckay, James R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (10) : 48S - 54S
  • [10] From research to practice: Lessons learned
    Toth, Sheree L.
    Manly, Jody Todd
    Nilsen, Wendy J.
    JOURNAL OF APPLIED DEVELOPMENTAL PSYCHOLOGY, 2008, 29 (04) : 317 - 325